Basal cell carcinoma (BCC) is a common skin cancer originating from basal cells in the epidermis. It is primarily caused by prolonged exposure to ultraviolet (UV) radiation. Clinically significant due to its potential for local invasion and destruction of surrounding tissues, BCC rarely metastasizes. The ICD-10 Code C44.719 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring proper management and treatment of this condition.
ICD-10 Code C44.719 specifically denotes basal cell carcinoma located on the skin of the left lower limb, including the hip. This code is used when documenting cases of BCC that are localized to this anatomical area, ensuring precise coding for treatment and billing purposes. It is essential for healthcare providers to use this code when diagnosing and managing patients with this type of skin cancer.
Basal cell carcinoma of the skin on the left lower limb, including the hip, arises from the uncontrolled growth of basal cells due to UV exposure. This malignancy progresses slowly and may cause significant local tissue damage if left untreated, necessitating prompt medical intervention.
In SOAP notes, ICD-10 Code C44.719 is utilized to document the diagnosis of basal cell carcinoma affecting the left lower limb, including the hip. This code plays a critical role in capturing patient symptoms, assessment findings, and treatment plans, ensuring comprehensive care in both acute and chronic settings.
ICD-10 Code C44.719 connects subjective patient reports and objective clinical findings to a formal diagnosis of basal cell carcinoma. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting electronic health record documentation standards.
Prompt treatment of basal cell carcinoma is essential to prevent local invasion and complications. Treatment options vary based on the tumor's size and location.
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C44.719 is crucial for accurate billing in hospital, ER, or outpatient settings for patients with basal cell carcinoma.
CPT Code | Description |
---|---|
11400 | Excision, benign skin lesion, face, ears, scalp, neck; excised diameter up to 4.0 cm. |
17311 | Destruction, malignant skin lesion, face, ears, scalp, neck; excised diameter up to 4.0 cm. |
99213 | Established patient office visit, Level 3. |
Common Questions About Using ICD-10 Code C44.719 for Basal cell carcinoma skin/ left lower limb, including hip
What are the common symptoms of basal cell carcinoma?
Common symptoms include a pearly or waxy bump, flat, scaly patches, and non-healing sores. Patients may also report tenderness or bleeding from the lesion.
How is basal cell carcinoma treated?
Treatment typically involves surgical excision of the tumor. Other options may include Mohs micrographic surgery or topical chemotherapy for superficial lesions.
Is basal cell carcinoma contagious?
No, basal cell carcinoma is not contagious. It is primarily caused by UV exposure and does not spread from person to person.
How often should patients be monitored after treatment?
Patients should have regular follow-up appointments, typically every 6 to 12 months, to monitor for recurrence or new lesions.
Clinical Notes
SOAP notes
DAP notes
AI medical notes